Join our community of smart investors

Smith & Nephew counts costs of cancelled operations

Surgical equipment firm's results reflect the huge fall in routine procedures previously revealed by Investors' Chronicle
Smith & Nephew counts costs of cancelled operations


  • Sales dropped 11 per cent while profits plunged more than two thirds
  • The IC recently found that elective operations performed by NHS trusts nearly halved last year

During the Covid-19 crisis, few will have paused to shed a tear for the woes of any FTSE 100 constituents, unless, of course, they hold shares in them. But the past year has been dire for the likes of medical equipment provider Smith & Nephew (SN.), which is counting its losses as hospitals cancel routine operations to deal with the pandemic.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in